• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Lung Cancer 2021, Part 1, An Issue of Thoracic Surgery Clinics

Lung Cancer 2021, Part 1, An Issue of Thoracic Surgery Clinics

9780323793537
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
574,56 zł
488,38 zł Zniżka 86,18 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 488,38 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis

In this issue of Thoracic Surgery Clinics, guest editor Farid Shamji brings considerable expertise to the topic of Lung Cancer.

Szczegóły produktu
Elsevier
91726
9780323793537
9780323793537

Opis

Rok wydania
2021
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Waga (g)
500
  • How to Design and Foster Thoracic Oncology Multidisciplinary Cancer Conferences
    Guiding Principles in the Management of Synchronous and Metachronous Primary Non-Small Cell Lung Cancer
    When Is It Safe to Operate for Lung Cancer? Selection of Fiscally Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and Pneumonectomy
    Management of Air Leaks and Residual Spaces Following Lung Resection
    Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy: Selection and Technique
    Role of the Thoracic Radiologist in the Evaluation and Management of Solid and Subsolid Lung Nodules
    Recognition and Management of Acute and Late Complications of Pneumonectomy: Clinical Cases and Treatment
    Constants and Currents in the Education and Training of General Thoracic Surgeons
    Assessment and Rehabilitation of the Compromised Patient Prior to Thoracotomy
    Is Small Cell Lung Cancer a Surgical Disease at the Present Time?
    Embolotherapy in Bronchial Hemorrhage
    Ethics for Thoracic Surgeons in the Management of Lung Cancer
    Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary Growths
    Implications of Adverse Biological Factors and Management of Solitary Fibrous Tumors of the Pleura
    Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer Be Predicted from Clinical Staging Alone?
Komentarze (0)